Table 2.
Drug classes most frequently ADR-implicated among the 194 inpatients with possible hospital-acquired ADRs and the 87 inpatients with probable hospital-acquired ADRs, Uganda, 2014
| Hospital-acquired ADRs, n (%) |
|||
|---|---|---|---|
| Drug class | All ADRs, n (%) | Possible ADR | Probable ADR |
| Single drug class | |||
| Antibacterials (Antibact) only | 61 (19) | 51 (26) | 12 (14) |
| Antiretrovirals (ART) only | 38 (12) | 0 ( 0) | 0 ( 0) |
| Uterotonics only | 26 ( 8) | 21 (11) | 5 (6) |
| Cardiovascular (CVS) drugs only | 21 (7) | 16 (8) | 7 (8) |
| Antimalarials (Antimal) only | 19 (6) | 12 (6) | 9 (10) |
| Analgesics only | 12 (4) | 10 (5) | 7 (8) |
| Antituberculous (AntiTB) drugs only | 8 (3) | 2 (1) | 0 (0) |
| Blood only | 6 (2) | 5 (3) | 1 (1) |
| Hypoglycaemics only | 6 (2) | 1 (1) | 0 (0) |
| Antifungals only | 3 (1) | 3 (2) | 1 (1) |
| Herbal medicines only | 2 (1) | 0 (0) | 0 (0) |
| Two or more drug classes | |||
| Antibact and ART | 17 (5) | 3 (2) | 2 (2) |
| Antibact and analgesic | 13 (4) | 12 (6) | 7 (8) |
| ART and AntiTBs | 5 (2) | 1 (1) | 1 (1) |
| ART+Antibact+AntiTB | 4 (1) | 1 (1) | 0 (0) |
| Antibact+AntiTB | 3 (1) | 3 (2) | 1 (1) |
| Central Nervous System | 3 (1) | 3 (2) | 3 (3) |
| Antibact+Uterotonic | 3 (1) | 3 (2) | 2 (2) |
| Antibact+Antimal | 2 (1) | 2 (1) | 2 (2) |
| ART and analgesic | 2 (1) | 2 (1) | 2 (2) |
| Other | 66 (21) | 43 (22) | 25 (29) |
| Total | 320 (100) | 194 (100) | 87 (100) |
ADR, adverse drug reaction.